Investments in Basic Cancer Research: Developing Crizotinib

NCI makes substantial investments in basic research, recognizing its fundamental importance in unraveling the complexities of cancer. A deeper understanding of cancer leads to new approaches for cancer prevention, screening, and treatment, like crizotinib to treat non-small cell lung cancer. Learn more about basic research in NCI’s Role in Cancer Research.